Immunomodulatory activity of itraconazole in lung

Tonny W. Naranjo, Damaris Lopera, Andrés Felipe Zuluaga, Luz Elena Cano

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Purpose: To evaluate the in vivo effects of ITC as an immunomodulator on various immunological mediators, including cytokines, chemokines and growth factors in pulmonary homogenates. Methods: Two experimental groups consisting of 25 BALB/c mice each were used: (a) PBS-treated mice and (b) ITC-treated mice (1 mg/mouse/day). The animals were treated daily via gavage for 8 weeks. Five mice from each group were sacrificed at 0, 4, 8, and 12 weeks and cytokine levels assessed in the supernatants of lung macerates using the Bio-Plex system. Five lungs from each experimental group, after 8 weeks of treatment, were used for histopathological analysis. Results: Compared with the control group, ITC-treated mice showed significant changes in the pulmonary levels of 50% of the molecules evaluated: IL-4, IL-10, IL-12p70, IL-13, TNF-α, eotaxin, MIP-1α, MIP-2, and LIF were significantly upregulated. In contrast, IL-1β, IL-15, IL-2, IL-1α, and VEGF were downregulated. Conclusion: Although histopathological examination did not show changes in lung cell infiltrates, ITC exerted a marked immunomodulatory effect at the pulmonary level in healthy BALB/c mice.

Idioma originalInglés
Páginas (desde-hasta)2603-2609
Número de páginas7
PublicaciónTropical Journal of Pharmaceutical Research
Volumen15
N.º12
DOI
EstadoPublicada - dic. 2016
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved.

Huella

Profundice en los temas de investigación de 'Immunomodulatory activity of itraconazole in lung'. En conjunto forman una huella única.

Citar esto